CARISMA Therapeutics (FRA:W2J) Buyback Yield % : -27.65 (As of Apr. 13, 2025)

View and export this data going back to 2023. Start your Free Trial

What is CARISMA Therapeutics Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

CARISMA Therapeutics's current buyback yield was -27.65%.

CARISMA Therapeutics Buyback Yield % Historical Data

The historical data trend for CARISMA Therapeutics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CARISMA Therapeutics Buyback Yield % Chart

CARISMA Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

-25.74

-12.75

CARISMA Therapeutics Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial									-26.25	-2.42	-3.62	-5.89	-13.68

Competitive Comparison of CARISMA Therapeutics's Buyback Yield %

For the Biotechnology subindustry, CARISMA Therapeutics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CARISMA Therapeutics's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CARISMA Therapeutics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where CARISMA Therapeutics's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

CARISMA Therapeutics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

CARISMA Therapeutics's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	2.284)	/	17.91075
	=	-12.75%

CARISMA Therapeutics's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	2.284)		/	17.91075
	=	-12.75%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

CARISMA Therapeutics Buyback Yield % Related Terms

Thank you for viewing the detailed overview of CARISMA Therapeutics's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

CARISMA Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARISMA Therapeutics Inc (FRA:W2J) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

CARM:USA

Address

3675 Market Street, Suite 200, Philadelphia, PA, USA, 19104

Website

https://www.carismatx.com

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

CARISMA Therapeutics Headlines

No Headlines